Innovate UK

Esox Biologics provides innovative and sustainable solutions for aquatic veterinary medicine. The company offers a disease prediction platform called eForesee, which uses data-driven predictions unique to individual farms. Regular monitoring of the aquatic environment and livestock health is a key component of their services. Esox Biologics utilizes extensive knowledge of the aquatic microbiome to prevent the spread of infectious diseases among aquatic animals by collecting environmental DNA and employing next-generation sequencing technologies.

Wordnerds specializes in text analytics, utilizing artificial intelligence and advanced linguistics to help businesses analyze customer feedback effectively. Their platform is designed to process large volumes of unstructured text, including online reviews and survey results, allowing clients to gain actionable insights from consumer data. By teaching computers to understand language and make informed decisions, Wordnerds transforms the internet into a vast resource for understanding customer preferences and behaviors. This capability enables companies to listen to their audience, comprehend the feedback, and identify suitable customers, ultimately enhancing their decision-making processes.

Naitive is a population health company focused on improving patient care through AI-enabled clinical pathways and medical device technology. The company develops software that employs artificial intelligence, clinical data, and digital interventions to enhance the identification, treatment, and coordination of care for chronic diseases. By leveraging advanced computational capabilities, Naitive aims to support clinicians in transforming patient care while simultaneously reducing costs, time, and the failure rates commonly associated with chronic disease management.

Bendi operates a data analytics platform that enhances supply chain tracking by providing real-time risk monitoring and traceability. Its software analyzes millions of data points from diverse sources such as news, legal cases, and social media across multiple languages worldwide. By focusing on human rights, environmental, and governance risks, Bendi aims to significantly reduce potential issues within supply chains. The platform serves various sectors, including fashion and textiles, retail, and advanced manufacturing, offering businesses actionable insights that help them save time and effectively audit their global supply chains.

AgriSound is an agri-tech company that specializes in advanced sound analysis for monitoring insect activity, particularly focusing on pollinators. The company has developed a pollination management platform that utilizes sound, environmental, and vision technology sensors to monitor and predict pollinator behavior across agricultural estates. This platform enables users, including beekeepers, farmers, and researchers, to assess hive status in near real-time through the use of predictive algorithms. By providing insights into insect activity and environmental changes affecting pollination, AgriSound's technology allows for remote management of beehives and supports timely decision-making. This innovation aims to enhance agricultural operations and promote biodiversity by suggesting appropriate actions to maintain optimal pollination conditions.

Presymptom Health is a medtech company that specializes in developing clinical decision support algorithms and diagnostic tests aimed at early illness detection. The company focuses on pre-symptomatic diagnostics, allowing for the identification of conditions such as sepsis up to three days before symptoms manifest. By enabling earlier intervention, Presymptom Health's innovations aim to enhance critical care outcomes and improve patient management. Through its portfolio of blood tests and algorithms, the company seeks to transform the way healthcare providers approach patient care, ultimately contributing to better health outcomes and potentially saving lives.

SökerData is a biotechnology company specializing in data analysis solutions for disease-related datasets. It has developed a data visualization platform designed to analyze biomarkers in clinical outcomes across different demographic groups. The platform offers tools for interpreting large datasets, supporting early drug discovery, and aiding researchers in understanding the impact of biomarkers on diverse populations, thereby facilitating informed decision-making and advancing disease outcome understanding.

AMPLY Discovery is a biotechnology company focused on utilizing machine learning and synthetic biology to discover novel drug and nutraceutical candidates. By employing a proprietary platform that combines in silico and in vitro approaches, AMPLY aims to develop first-in-class therapeutic molecules to address significant health challenges, including cancer, metabolic diseases, and multi-drug resistant infections. The company’s innovative engine digitizes the natural diversity of life, allowing for the identification of potential drug candidates based on their functional properties. This methodology enhances the predictability and cost-effectiveness of drug discovery, enabling research entities to uncover new treatments for difficult-to-treat diseases.

Holly Health is a digital health coaching application that assists individuals in transforming their health intentions into actionable daily habits for improved mental and physical wellbeing. Utilizing proprietary AI systems, the service mimics the support of a human health coach, offering personalized guidance to users. The application features tools such as habit reminders, tailored health content, and progress tracking, all aimed at helping users establish and maintain healthier routines. Recognized as one of the top health apps for weight management, stress reduction, wellness, and sleep, Holly Health achieved a notable evaluation score of 89% from ORCHA, a leading health app assessment organization. Launched internationally in Summer 2021, the company aims to support five million individuals by 2025 and is actively partnering with primary care practices in the UK, having established over 100 collaborations to date.

Holly Health is a digital health coaching application that assists individuals in transforming their health intentions into actionable daily habits for improved mental and physical wellbeing. Utilizing proprietary AI systems, the service mimics the support of a human health coach, offering personalized guidance to users. The application features tools such as habit reminders, tailored health content, and progress tracking, all aimed at helping users establish and maintain healthier routines. Recognized as one of the top health apps for weight management, stress reduction, wellness, and sleep, Holly Health achieved a notable evaluation score of 89% from ORCHA, a leading health app assessment organization. Launched internationally in Summer 2021, the company aims to support five million individuals by 2025 and is actively partnering with primary care practices in the UK, having established over 100 collaborations to date.

The Sixth Sense in medical Diagnostics. At AINOSTICS we are working to identify the earliest biological signs of some of our society’s most devastating neurodegenerative conditions such as Alzheimer’s disease, Huntington's and MS, providing the best chance of success in the development of potential preventions and therapeutics by Pharma, and precise treatment planning by clinicians. We combine the most exciting medical imaging innovations with the best of artificial intelligence solutions to unlock the future of personalised diagnosis, prognosis, and therapy monitoring and planning.

Bendi operates a data analytics platform that enhances supply chain tracking by providing real-time risk monitoring and traceability. Its software analyzes millions of data points from diverse sources such as news, legal cases, and social media across multiple languages worldwide. By focusing on human rights, environmental, and governance risks, Bendi aims to significantly reduce potential issues within supply chains. The platform serves various sectors, including fashion and textiles, retail, and advanced manufacturing, offering businesses actionable insights that help them save time and effectively audit their global supply chains.

Brainomix Limited, established in 2010 as a spin-out from the University of Oxford, develops advanced imaging biomarkers and software solutions aimed at enhancing clinical decision-making for neurological and cerebrovascular disorders. The company's flagship product, e-Stroke, employs state-of-the-art artificial intelligence algorithms to automate the interpretation of brain scans, specifically for acute ischemic stroke patients. This tool assists physicians in identifying and quantifying early stroke damage, thereby facilitating timely and informed treatment decisions. In addition to e-Stroke, Brainomix offers other software products such as e-ASPECTS, which automates the Alberta Stroke Program Early CT Score, and e-CTA, which standardizes the assessment of large vessel occlusion locations. These innovative solutions address the critical need for rapid and consistent evaluations of brain CT scans, ultimately optimizing patient outcomes and ensuring that stroke patients receive appropriate care in a timely manner. The company is headquartered in Oxford, United Kingdom.

FruitCast specializes in AI-driven data analytics for soft fruit growers. It employs non-destructive methods to daily measure individual fruit numbers, weight, and maturity of millions of berries, then combines this data with other sources to provide accurate yield forecasts up to six weeks ahead. This enables businesses and farmers to optimize labor scheduling, enhance supply chain efficiency, and make informed decisions.

MeVitae operates an online recruitment platform designed to enhance diversity and inclusivity in hiring processes for organizations. The platform utilizes data-driven technology to assist businesses in attracting, screening, and retaining top talent while ensuring a fair approach to building diverse and productive teams. By integrating seamlessly with existing applicant tracking systems (ATS) and customer relationship management (CRM) tools, MeVitae allows companies to maintain their current processes without disruption. The solution emphasizes the importance of personalized hiring that aligns with a company's culture, all while eliminating algorithmic and neurological biases. This enables clients to achieve a more transparent and efficient automated talent acquisition process.

The Sixth Sense in medical Diagnostics. At AINOSTICS we are working to identify the earliest biological signs of some of our society’s most devastating neurodegenerative conditions such as Alzheimer’s disease, Huntington's and MS, providing the best chance of success in the development of potential preventions and therapeutics by Pharma, and precise treatment planning by clinicians. We combine the most exciting medical imaging innovations with the best of artificial intelligence solutions to unlock the future of personalised diagnosis, prognosis, and therapy monitoring and planning.

Watermarq specializes in providing decision-useful insights to promote investment and collective action for water security. The company utilizes innovative technologies, including artificial intelligence and machine learning, to analyze satellite imagery and generate high-resolution, basin-specific data on water availability, quality, value, and access. This data is designed to assist clients in the public, private, and financial services sectors in making informed decisions regarding environmental, social, and governance risks. By focusing on operational insights, Watermarq enables its clients to estimate future risks based on observed data, rather than relying on speculation.

DeepMirror is a software platform that integrates human expertise with artificial intelligence to enhance drug discovery processes. The company specializes in predicting the properties of molecules and their affinity for various targets, thereby streamlining the research and development efforts of biopharmaceutical teams. By employing structured perception and feature fusion techniques, DeepMirror's platform delivers advanced 3D insights while maintaining low power consumption. This capability simplifies the analysis of complex data, ultimately allowing researchers to focus on the most promising drug candidates and conduct fewer experiments, leading to more efficient drug development.

Syndi is a digital health platform that focuses on enhancing health outcomes through technology and research, initially targeting mental health. The platform employs machine learning and digital phenotyping to provide personalized and immediate care by utilizing moment-by-moment passive smartphone data collection. This approach allows for effective and accessible support tailored to individual needs. Syndi's services aim to improve the treatment of invisible disabilities by facilitating connections between patients and healthcare providers, while also measuring the effectiveness of its applications and digital services. Through its innovative solutions, Syndi seeks to transform the way people access and engage with healthcare.

Elaniti leverages advances in machine learning and DNA sequencing to enhance soil biology insights for farmers and agronomists, facilitating informed decision-making. The company offers a predictive analytics service that links soil biology to essential crop health outcomes, such as yield, disease prevalence, and nutrient content. This approach enables growers to optimize input efficiency, thereby saving time and costs while promoting environmental sustainability. Elaniti's platform addresses the data gap in soil health by employing a combination of physics, microbiology, and biochemistry to improve crop health and yields. By focusing on the soil microbiome, Elaniti supports the transition to regenerative agriculture, emphasizing the importance of beneficial microbial activity and biodiversity. Through its innovative crop prediction insights, Elaniti aims to highlight the value of soil's complex biological makeup and contribute to a data-driven transition towards Net-Zero agriculture.

Appella AI is revolutionizing retail e-commerce with hyper-personalized AI personal shoppers. By recreating the in-store shopping experience online, we help brands deliver tailored journeys that boost customer satisfaction, drive conversions, and foster loyalty. Leveraging cutting-edge recommender systems and large language models (LLMs), Appella’s AI provides conversational, intuitive shopping assistance. Beyond recommending products based on preferences and behavior, our solution offers trend insights and personalized marketing, ensuring every interaction reflects the brand’s unique identity. Launching on Shopify, Appella empowers e-commerce retailers to elevate their customer experience and unlock actionable insights to fuel growth.

Drill Surgeries is a technology company specializing in AI-powered surgical navigation systems for trauma and orthopedic procedures. Their proprietary AI algorithms and mixed reality technologies aim to significantly reduce operating room time and enhance surgical precision, thereby minimizing failure rates and unnecessary radiation exposure. By doing so, they help hospitals save substantial costs per operation.

AMPLY Discovery is a biotechnology company focused on utilizing machine learning and synthetic biology to discover novel drug and nutraceutical candidates. By employing a proprietary platform that combines in silico and in vitro approaches, AMPLY aims to develop first-in-class therapeutic molecules to address significant health challenges, including cancer, metabolic diseases, and multi-drug resistant infections. The company’s innovative engine digitizes the natural diversity of life, allowing for the identification of potential drug candidates based on their functional properties. This methodology enhances the predictability and cost-effectiveness of drug discovery, enabling research entities to uncover new treatments for difficult-to-treat diseases.

Built AI is a company that provides a real estate investment analysis platform aimed at assisting professionals in the commercial property sector. The platform utilizes artificial intelligence and natural language processing to enhance the analysis of investment opportunities. It offers a range of tools for screening and prospecting, investment analysis, and risk assessment, while also incorporating insights from historical deal pipelines and existing portfolios. By leveraging key local factors and social referencing, Built AI enables its clients to make informed decisions more efficiently, thus gaining a competitive edge in the real estate market.

PhysioMedics is a healthcare technology company focused on enhancing the management of musculoskeletal disorders through its online software solutions. The company has developed a self-assessment platform that offers data analytics, personalized self-help advice, and information to connect back pain sufferers with appropriate treatment pathways. This approach enables patients to take an active role in their healthcare, leading to improved outcomes. Additionally, PhysioMedics' platform assists organizations in reducing costs associated with absenteeism and enhances overall efficiency in managing musculoskeletal conditions.

DeepMirror is a software platform that integrates human expertise with artificial intelligence to enhance drug discovery processes. The company specializes in predicting the properties of molecules and their affinity for various targets, thereby streamlining the research and development efforts of biopharmaceutical teams. By employing structured perception and feature fusion techniques, DeepMirror's platform delivers advanced 3D insights while maintaining low power consumption. This capability simplifies the analysis of complex data, ultimately allowing researchers to focus on the most promising drug candidates and conduct fewer experiments, leading to more efficient drug development.

Watermarq specializes in providing decision-useful insights to promote investment and collective action for water security. The company utilizes innovative technologies, including artificial intelligence and machine learning, to analyze satellite imagery and generate high-resolution, basin-specific data on water availability, quality, value, and access. This data is designed to assist clients in the public, private, and financial services sectors in making informed decisions regarding environmental, social, and governance risks. By focusing on operational insights, Watermarq enables its clients to estimate future risks based on observed data, rather than relying on speculation.

FourJaw Manufacturing Analytics is a provider of a machine-agnostic data analytics platform designed to enhance machining productivity through data-driven insights. The platform offers real-time visibility into shop floor operations, allowing users to monitor the status of each machine and identify unplanned downtime. By utilizing cloud-based technology, FourJaw enables small and medium-sized enterprises (SMEs) in the manufacturing sector to access critical analytics that support improved operational efficiency and productivity. Through its comprehensive approach, FourJaw aims to empower manufacturers with the tools necessary to optimize their processes and make informed decisions.

BIOStress is a company focused on enhancing the understanding and management of stress through innovative technology. It has developed a proprietary algorithm that accurately measures stress levels using data from existing biometric devices. By leveraging this technology, BIOStress offers a platform that objectively monitors workplace stress, providing employees with personalized insights into their stress levels. This approach not only aims to improve individual well-being but also enhances overall productivity within organizations. By focusing on the balance between well-being and stress management, BIOStress seeks to foster healthier work environments and better performance outcomes.

Medwise.ai offers a customizable search platform designed to support clinical decision-making for healthcare professionals. Utilizing natural language processing and artificial intelligence, the platform enables doctors to efficiently access and organize medical knowledge. By leveraging real-world data, Medwise.ai provides valuable intelligence and insights to various stakeholders within the healthcare ecosystem. This innovative approach aims to enhance the professional capabilities of doctors, ultimately improving patient care and outcomes.

3AI is a machine learning company dedicated to building the world’s most advanced and usable AI for investment professionals, founded by an award-winning data science team of industry experts. 3AI is enhancing investor decision making with big data predictions and insights, enabling better judgement and results. ALBA is 3AI's self-learning equity prediction intelligence, producing reliably accurate global equity forecasts and insights. ALBA's top picks have consistently outperformed the S&P 500 since the 1980s.

Abtrace specializes in AI-based solutions designed to enhance medical expertise and streamline healthcare processes. The company focuses on developing clinical decision-making tools that transform the detection, monitoring, and treatment of chronic and long-term health conditions. By utilizing machine learning and big data techniques, Abtrace's software analyzes patient data to provide insights that help healthcare professionals manage current diseases and identify early signs of new conditions. This approach not only improves patient safety but also reduces the misuse of antibiotics and enhances treatment outcomes. Additionally, Abtrace's solutions automate key aspects of disease monitoring, enabling general practitioners and healthcare assistants to make informed decisions and deliver effective care while lowering practice costs and saving time.

Oxford Heartbeat develops innovative medical device software designed to enhance the planning and execution of cardiovascular surgeries. The company's platform allows surgeons to visualize critical information about a patient's anatomy by providing insights into blood vessels, tissue, and bone structures. This advanced technology, which leverages predictive computations, big data, and artificial intelligence, enables medical professionals to rehearse procedures and select the most effective surgical scenarios tailored to individual patients. By improving surgical preparation, Oxford Heartbeat aims to reduce complication rates and associated healthcare costs while enhancing overall patient care. The company is currently conducting prospective clinical trials in NHS hospitals, supported by the UK government's AI in Health and Care Awards.

Predictiva is a company that provides an artificial intelligence platform designed to enhance financial trading and investment management using advanced Deep Reinforcement Learning algorithms. It offers solutions that cater to various financial assets, focusing on optimizing decision-making in complex financial markets. By leveraging cutting-edge AI technology, Predictiva aims to deliver predictable profits while minimizing risks, enabling users to engage in a more accurate, data-driven approach to trading. The platform is accessible to users without a background in AI or data science, utilizing autonomous machine learning algorithms to simplify the trading process and enhance financial intelligence for traders and investment managers.

Glamorous AI develops an artificial intelligence-based drug discovery platform that focuses on low-data scenarios in pharmaceutical research. The platform utilizes AI to identify and optimize novel chemical compounds, facilitating the discovery of new medicines by analyzing prior experimental results. It is designed to handle sparse, noisy, and small datasets, making it particularly effective for tackling complex drug discovery challenges. By leveraging a large repository of pre-trained and customizable AI models, Glamorous AI enables researchers to screen extensive chemical libraries and address novel and first-in-class therapeutic targets, ultimately driving innovation in drug development and contributing to the advancement of treatments for various diseases.

Bendi operates a data analytics platform that enhances supply chain tracking by providing real-time risk monitoring and traceability. Its software analyzes millions of data points from diverse sources such as news, legal cases, and social media across multiple languages worldwide. By focusing on human rights, environmental, and governance risks, Bendi aims to significantly reduce potential issues within supply chains. The platform serves various sectors, including fashion and textiles, retail, and advanced manufacturing, offering businesses actionable insights that help them save time and effectively audit their global supply chains.

NovaBleep is an innovative communications infrastructure layer specifically designed for hospitals. Various modular components are included to replace communication streams such as pagers, referral systems, fault reporting systems, concern escalation systems, ward chats etc. By streamlining and digitalising these essential communication processes, NovaBleep revolutionises the way hospitals operate. The flow of a patient from entering an ED to discharge/death represents the flow of data. Not all of this data is yet digitalised. Data will be aggregated using NovaBleep for use in Machine Learning to predict the trajectory of patients, and to potentially predict mortality.

IgniteData is a technology company focused on transforming clinical trials through its cloud-based virtual research assistant, Archer. This solution serves as a global electronic health record (EHR) to electronic data capture (EDC) platform, facilitating secure transmission of clinical data. By automating patient recruitment and enhancing real-world evidence processes, IgniteData enables researchers to efficiently collect trial data and accelerate study timelines. The company's innovations aim to improve the quality of clinical research while reducing the workloads for clients, ultimately helping to deliver critical therapies to patients more swiftly.

Etiq AI develops a lightweight AI testing tool that assists companies in assessing their data and models. The platform is designed to identify errors, risks, and potential bias issues, offering repair recommendations to enhance accuracy. By providing real-time analytics and decision-making capabilities, Etiq AI enables organizations, particularly in the financial sector, to address bias and mitigate associated risks. This functionality allows firms to deploy AI applications more effectively, ultimately leading to improved business outcomes.

FinCrime Dynamics specializes in advanced simulation and financial crime analytics, aiming to enhance the safety of the financial system through the effective deployment of artificial intelligence. The company utilizes enriched synthetic data to model the dynamics of fraud and money laundering, creating customized scenarios that help financial organizations understand and address various threats. By leveraging its expertise in financial crime analytics, FinCrime Dynamics provides businesses with a robust benchmark for detecting and mitigating risks associated with financial crime. The company's focus on simulation and compliance positions it at the forefront of the fintech industry, helping organizations navigate the complexities of fraud in an increasingly digital landscape.

Abtrace specializes in AI-based solutions designed to enhance medical expertise and streamline healthcare processes. The company focuses on developing clinical decision-making tools that transform the detection, monitoring, and treatment of chronic and long-term health conditions. By utilizing machine learning and big data techniques, Abtrace's software analyzes patient data to provide insights that help healthcare professionals manage current diseases and identify early signs of new conditions. This approach not only improves patient safety but also reduces the misuse of antibiotics and enhances treatment outcomes. Additionally, Abtrace's solutions automate key aspects of disease monitoring, enabling general practitioners and healthcare assistants to make informed decisions and deliver effective care while lowering practice costs and saving time.

Elixivity specializes in quantifying and benchmarking the impact of people-related factors on financial performance through the use of artificial intelligence. The company has developed a data management platform that analyzes extensive datasets to identify key patterns related to personnel. By visualizing different scenarios and predicting performance across various metrics, Elixivity empowers enterprises to make informed, data-driven decisions. Additionally, the platform enables organizations to assess and compare their inclusion and diversity metrics against those of competitors, sectors, and geographical benchmarks, facilitating strategic improvements in these critical areas.

Intelligent AI is a developer of a platform focused on risk underwriting management, aimed at reducing business interruption claims and addressing underinsurance in property underwriting. Established in April 2022 by Anthony Peake in Exeter, Devon, the company offers a solution that integrates global location intelligence with artificial intelligence, data science, satellite image analysis, and risk data sets. This comprehensive platform provides insurers and corporations with a 360-degree view of risks associated with their commercial property portfolios. By enabling real-time measurement, prediction, and mitigation of these risks, Intelligent AI equips businesses with actionable insights to protect their interests and enhance their risk management strategies.

Albus Health, a startup emerging from the University of Oxford, has created an intelligent nocturnal monitoring platform designed for personalized home use. This system facilitates passive, contactless, and objective monitoring of various symptoms and environmental metrics, making it particularly useful for assessing nocturnal conditions. The platform has been successfully commercialized and is currently employed by leading pharmaceutical companies to monitor nocturnal symptoms during clinical trials. Additionally, it has the capability to predict respiratory emergencies, thus enhancing patient safety and outcomes.

Medwise.ai offers a customizable search platform designed to support clinical decision-making for healthcare professionals. Utilizing natural language processing and artificial intelligence, the platform enables doctors to efficiently access and organize medical knowledge. By leveraging real-world data, Medwise.ai provides valuable intelligence and insights to various stakeholders within the healthcare ecosystem. This innovative approach aims to enhance the professional capabilities of doctors, ultimately improving patient care and outcomes.

Game Doctor develops data-driven gamification technology. They offer services that include big data, mobile applications, health promotion, health marketing, public health, engagement, and behavior change.

Discova Health Ltd is a digital health company that offers an AI-powered mental health and resilience web application designed for corporations and the public sector. The platform provides personalized, evidence-based self-help interventions and action plans for prevalent mental health issues within minutes of sign-up. Unlike traditional solutions that merely address problems, Discova's approach focuses on predicting the most beneficial support pathways by analyzing data on user engagement, motivation, and behavior change. With over 1.9 million potential action plan combinations derived from its knowledge networks, the platform aims to deliver tailored support that can help prevent crises. Additionally, it empowers employees to take charge of their mental health through customized plans that incorporate professional, complementary, and peer interventions, promoting a supportive environment within organizations.

NovaBleep is an innovative communications infrastructure layer specifically designed for hospitals. Various modular components are included to replace communication streams such as pagers, referral systems, fault reporting systems, concern escalation systems, ward chats etc. By streamlining and digitalising these essential communication processes, NovaBleep revolutionises the way hospitals operate. The flow of a patient from entering an ED to discharge/death represents the flow of data. Not all of this data is yet digitalised. Data will be aggregated using NovaBleep for use in Machine Learning to predict the trajectory of patients, and to potentially predict mortality.

The Sixth Sense in medical Diagnostics. At AINOSTICS we are working to identify the earliest biological signs of some of our society’s most devastating neurodegenerative conditions such as Alzheimer’s disease, Huntington's and MS, providing the best chance of success in the development of potential preventions and therapeutics by Pharma, and precise treatment planning by clinicians. We combine the most exciting medical imaging innovations with the best of artificial intelligence solutions to unlock the future of personalised diagnosis, prognosis, and therapy monitoring and planning.

Appt is making preventive healthcare effortless and accessible. Appt uses behavioural economics and data analytics to increase the uptake of preventive healthcare appointments - earning practices additional income and helping the delivery of nationally set prevention targets. Furthermore, through end-to-end automation of the call and recall process, Appt reduces cumbersome practice workload saving practice staff valuable time.

We help D2C brands grow the value of their customers faster by providing software, intelligence and expertise. Our Customer Data Intelligence Platform creates a genuine single point of truth, for every customer, by consolidating and deduplicating each data point. This enables brands to: • Quickly diagnose performance of marketing activity, accelerating the ability to test, learn and optimise. • Identify true VIPs and create strategies that build and track their engagement • Easy revenue forecast modelling, so brands know what it'll take to hit whatever revenue targets they're trying to achieve in seconds. • See how recent activity impacts predicted Customer Lifetime Value, so they can stop, continue or adjust to optimise acquisition. Our CRM personal data fields tool takes multiple customer data sources as inputs and uses customised logic to create rich metadata that can be used to personalise campaigns. This enables brands to: • To trigger, segment and personalise communications via their existing email marketing tools • Use multiple sources of customer data to increase personalisation, not just that which sits in a duplicated state within the e-commerce platform.

Healum is a developer of connected software and applications aimed at enhancing self-management for individuals with long-term health conditions. The company's AI-powered platform offers personalized care and support by leveraging data-driven insights and evidence-based behavioral interventions. Healum's tools enable patients to effectively monitor and understand both their physical and mental health, while also providing healthcare professionals with the means to assist patients in managing chronic conditions. This approach promotes a collaborative environment where patients receive customized support tailored to their unique health needs.

Albus Health, a startup emerging from the University of Oxford, has created an intelligent nocturnal monitoring platform designed for personalized home use. This system facilitates passive, contactless, and objective monitoring of various symptoms and environmental metrics, making it particularly useful for assessing nocturnal conditions. The platform has been successfully commercialized and is currently employed by leading pharmaceutical companies to monitor nocturnal symptoms during clinical trials. Additionally, it has the capability to predict respiratory emergencies, thus enhancing patient safety and outcomes.

Established, multi award-winning digital-health company, offering a world-class real-world evidence (RWE) data portfolio and analytics. Scientific rigor, gold-standard security and information governance - including GDPR and HIPAA - are combined with inclusive, patient-centric design in Vitaccess' pioneering and flexible digital platform. Patient- or clinician-reported data are anonymised then transferred to proprietary dashboards, offering real-time insights, and shortening publication times.

CorrosionRADAR Ltd, established in 2017 and headquartered in Cambridge, UK, specializes in developing and implementing advanced corrosion monitoring systems. The company's core technology involves patent-pending distributed sensing, combined with Industrial Internet of Things (IIoT) and sophisticated analytics, enabling predictive corrosion management. CorrosionRADAR serves a broad range of industries, including oil and gas, power and utilities, industrial manufacturing, and civil infrastructure, offering solutions for refineries, offshore and onshore rigs, power plants, pipelines, and structures. By detecting and predicting hidden corrosion, the company helps clients maintain safety, reliability, and cost-effectiveness in their operations.

Oxford Heartbeat develops innovative medical device software designed to enhance the planning and execution of cardiovascular surgeries. The company's platform allows surgeons to visualize critical information about a patient's anatomy by providing insights into blood vessels, tissue, and bone structures. This advanced technology, which leverages predictive computations, big data, and artificial intelligence, enables medical professionals to rehearse procedures and select the most effective surgical scenarios tailored to individual patients. By improving surgical preparation, Oxford Heartbeat aims to reduce complication rates and associated healthcare costs while enhancing overall patient care. The company is currently conducting prospective clinical trials in NHS hospitals, supported by the UK government's AI in Health and Care Awards.

CorrosionRADAR Ltd, established in 2017 and headquartered in Cambridge, UK, specializes in developing and implementing advanced corrosion monitoring systems. The company's core technology involves patent-pending distributed sensing, combined with Industrial Internet of Things (IIoT) and sophisticated analytics, enabling predictive corrosion management. CorrosionRADAR serves a broad range of industries, including oil and gas, power and utilities, industrial manufacturing, and civil infrastructure, offering solutions for refineries, offshore and onshore rigs, power plants, pipelines, and structures. By detecting and predicting hidden corrosion, the company helps clients maintain safety, reliability, and cost-effectiveness in their operations.

CorrosionRADAR Ltd, established in 2017 and headquartered in Cambridge, UK, specializes in developing and implementing advanced corrosion monitoring systems. The company's core technology involves patent-pending distributed sensing, combined with Industrial Internet of Things (IIoT) and sophisticated analytics, enabling predictive corrosion management. CorrosionRADAR serves a broad range of industries, including oil and gas, power and utilities, industrial manufacturing, and civil infrastructure, offering solutions for refineries, offshore and onshore rigs, power plants, pipelines, and structures. By detecting and predicting hidden corrosion, the company helps clients maintain safety, reliability, and cost-effectiveness in their operations.

MyWay Digital Health is an online self-management platform designed to enhance the lives of individuals with long-term health conditions, particularly diabetes. The platform offers users access to their health records, personalized advice, and educational resources, empowering them to take control of their health. Additionally, it provides tools for clinicians that support population analytics and decision-making, thereby facilitating improved health outcomes for users. Through its data-driven technology solutions, MyWay Digital Health aims to deliver comprehensive support for managing chronic conditions on a global scale.

CorrosionRADAR Ltd, established in 2017 and headquartered in Cambridge, UK, specializes in developing and implementing advanced corrosion monitoring systems. The company's core technology involves patent-pending distributed sensing, combined with Industrial Internet of Things (IIoT) and sophisticated analytics, enabling predictive corrosion management. CorrosionRADAR serves a broad range of industries, including oil and gas, power and utilities, industrial manufacturing, and civil infrastructure, offering solutions for refineries, offshore and onshore rigs, power plants, pipelines, and structures. By detecting and predicting hidden corrosion, the company helps clients maintain safety, reliability, and cost-effectiveness in their operations.

Albus Health, a startup emerging from the University of Oxford, has created an intelligent nocturnal monitoring platform designed for personalized home use. This system facilitates passive, contactless, and objective monitoring of various symptoms and environmental metrics, making it particularly useful for assessing nocturnal conditions. The platform has been successfully commercialized and is currently employed by leading pharmaceutical companies to monitor nocturnal symptoms during clinical trials. Additionally, it has the capability to predict respiratory emergencies, thus enhancing patient safety and outcomes.

We help D2C brands grow the value of their customers faster by providing software, intelligence and expertise. Our Customer Data Intelligence Platform creates a genuine single point of truth, for every customer, by consolidating and deduplicating each data point. This enables brands to: • Quickly diagnose performance of marketing activity, accelerating the ability to test, learn and optimise. • Identify true VIPs and create strategies that build and track their engagement • Easy revenue forecast modelling, so brands know what it'll take to hit whatever revenue targets they're trying to achieve in seconds. • See how recent activity impacts predicted Customer Lifetime Value, so they can stop, continue or adjust to optimise acquisition. Our CRM personal data fields tool takes multiple customer data sources as inputs and uses customised logic to create rich metadata that can be used to personalise campaigns. This enables brands to: • To trigger, segment and personalise communications via their existing email marketing tools • Use multiple sources of customer data to increase personalisation, not just that which sits in a duplicated state within the e-commerce platform.

Vivacity Labs Ltd. specializes in providing hyper-local data solutions for smart cities and intelligent transport systems. Founded in 2015 and based in London, the company offers a range of services that include car parking and bus occupancy sensing, traffic monitoring, and insights into rail management through predictive analytics. To enhance urban transport management, Vivacity is deploying thousands of sensors across the UK, including in Milton Keynes, which is being developed as the country's first transport-focused smart city. These sensors leverage machine learning and artificial intelligence to analyze video feeds and generate valuable data on traffic patterns, cyclist movements, and more. Vivacity's advanced predictive algorithms aim to improve road safety and reduce congestion by providing transport managers with unprecedented insights into future transport scenarios.

Current Health Limited, founded in 2014 and based in Edinburgh, United Kingdom, specializes in developing wearable healthcare devices that monitor patients' vital signs. These devices are designed to measure key health metrics such as oxygen saturation, respiration rate, pulse rate, temperature, motion, activity, and posture, allowing for the early identification of unwell patients and timely medical intervention. The company also offers a patient monitoring platform that facilitates home-based care by enabling patients to share daily activities, report symptoms, and respond to structured questionnaires for their healthcare providers. By focusing on remote patient management, Current Health aims to reduce healthcare risks and costs while enhancing patient engagement and monitoring. Formerly known as Snap40 Limited, the company rebranded in December 2018 to better reflect its mission.

Oxford Heartbeat develops innovative medical device software designed to enhance the planning and execution of cardiovascular surgeries. The company's platform allows surgeons to visualize critical information about a patient's anatomy by providing insights into blood vessels, tissue, and bone structures. This advanced technology, which leverages predictive computations, big data, and artificial intelligence, enables medical professionals to rehearse procedures and select the most effective surgical scenarios tailored to individual patients. By improving surgical preparation, Oxford Heartbeat aims to reduce complication rates and associated healthcare costs while enhancing overall patient care. The company is currently conducting prospective clinical trials in NHS hospitals, supported by the UK government's AI in Health and Care Awards.

Sensing Feeling Limited, established in 2013 and based in London, specializes in developing IoT-based human behavior sensing products for businesses. The company leverages advanced technology, including computer vision and machine learning, to provide real-time measurement of behavioral indices. Sensing Feeling's products enhance the reliability and effectiveness of analyzing aggregated human behavior in physical spaces, allowing organizations to better understand risks, improve safety, and enhance customer experiences. By utilizing smart visual sensing software, the company enables accurate, simultaneous behavior sensing of individuals and groups, as well as vehicles and other assets, thereby assisting businesses in managing safety and risk within critical operational environments.

Big Data Partnership specializes in helping organizations across various industries become more data-driven through the implementation of data science and advanced big data technologies. As companies generate data at an unprecedented rate, particularly unstructured data from sources like social networks and machine data, Big Data Partnership assists in managing this complexity. The firm emphasizes the economic viability of transforming data into actionable insights, which can drive new revenue streams and provide a competitive edge over traditional business intelligence solutions. Their services include consulting in big data engineering, data science, and certified training, focusing on technologies such as the Apache Hadoop ecosystem, Apache Spark, and Apache Cassandra. By partnering with clients to develop and deliver scalable solutions, they also provide training to ensure staff are equipped with the necessary skills to navigate the evolving data landscape.

Outcomes Based Healthcare focuses on implementing outcome-based strategies within the healthcare system, emphasizing collaboration with patients to define and measure health outcomes. The organization develops technology solutions aimed at assisting healthcare commissioners and providers in tracking and analyzing outcomes for specific population segments. By integrating health and non-health datasets and employing machine learning techniques, it aims to predict health outcomes effectively. Additionally, the company offers tools such as an outcome library and management platform, which support population health management and facilitate the execution of value-based healthcare strategies and outcomes-based contracts. With a team comprising professionals from diverse fields including medicine, business, and computer science, Outcomes Based Healthcare is dedicated to designing patient-centered care and enhancing the healthcare system through innovative technology.

Perspectum is a global medical technology company that focuses on improving care for patients with liver disease, diabetes, and cancer. By utilizing advanced imaging and genetics, the company emphasizes precision medicine to enhance early detection, diagnosis, and targeted treatment of complex health issues. Perspectum's diverse team, which includes physicians, biomedical scientists, engineers, and technologists, works collaboratively to develop innovative digital technologies. Their aim is to empower both patients and clinicians by providing quantitative health assessments, enabling more effective management of metabolic diseases and multi-organ pathology.

Warwick Analytics specializes in advanced predictive analytics and process automation, focusing on transforming raw data into structured formats. The company's flagship product, PrediCX, employs proprietary technology known as Optimised Learning to automatically classify textual data using machine learning. This approach minimizes the need for human input while maximizing accuracy in data labeling. PrediCX is versatile, providing insights into verbatim text data, facilitating Robotic Process Automation, and conducting sentiment analysis for consumer feedback. By lowering the cost barriers associated with predictive analytics, Warwick Analytics enables customers to enhance quality, improve throughput, and better predict customer behavior and associated risks.